MRX Medical develops pharmaceutical cannabinoid oils that are consistent from batch to batch and suitable for use in clinical trials. MRX has developed a range of cannabinoid formulations that target the treatment of complex and chronic inflammatory pain conditions, with a focus on quality, consistency and evidence.

MRX formulations will initially be offered as unlicensed Cannabis Based Products for Medicinal Use in humans, and our ambition is to have MRX patent pending medicines licensed and offered via the NHS.

To find out more about MRX Medical, visit